Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
636.24B
Market cap636.24B
Price-Earnings ratio
30.30
Price-Earnings ratio30.30
Dividend yield
2.02%
Dividend yield2.02%
Average volume
7.01M
Average volume7.01M
High today
$264.59
High today$264.59
Low today
$260.13
Low today$260.13
Open price
$261.60
Open price$261.60
Volume
5.90M
Volume5.90M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$184.66
52 Week low$184.66

Stock Snapshot

With a market cap of 636.24B, Johnson & Johnson(JNJ) trades at $264.30. The stock has a price-to-earnings ratio of 30.30 and currently yields dividends of 2.02%.

As of 2026-10-12, Johnson & Johnson(JNJ) stock has fluctuated between $260.13 and $264.59. The current price stands at $264.30, placing the stock +1.6% above today's low and -0.1% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 5.9M, compared to an average daily volume of 7.01M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

JNJ News

Reuters 5h
Penguins acquire Sabres D Ryan Johnson for Caleb Jones, Daniel Laatsch - Reuters

...

Penguins acquire Sabres D Ryan Johnson for Caleb Jones, Daniel Laatsch - Reuters
The Motley Fool 5h
Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never Sell

One type of stock will reward you no matter which direction the major indexes take, and that's the dividend stock. These companies share the wealth with investo...

Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never Sell
TipRanks 7h
Johnson & Johnson reports three-year data from Phase 3 GALAXI 2 and 3 studies

Johnson & Johnson announced new three-year data from the Phase 3 GALAXI 2 and 3 studies showing durable efficacy and a consistent safety profile for TREMFYA in...

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
22.2%
Sell
7.4%

More JNJ News

Benzinga 8h
JPMorgan Chase Could Swing $28 Billion After Earnings

Earnings season keeps the tape honest, and the options market is already laying down markers for how much volatility traders expect when results hit on Tuesday,...

JPMorgan Chase Could Swing $28 Billion After Earnings
TipRanks 8h
Will Johnson & Johnson Stock Rise or Fall After Q3 Earnings?

Johnson & Johnson (JNJ) stock was up 0.72% on Monday ahead of the diversified healthcare company’s Q3 2026 earnings report. This report will be released before...

Benzinga 11h
Dow Jones Industrial Average Gets Spotlight: 5 Earnings Reports Representing 25% of ETF’s Assets On Deck

Earnings season kicks off this week as several of the largest financial companies report quarterly financial results. The week is a big one for the Dow Jones In...

Dow Jones Industrial Average Gets Spotlight: 5 Earnings Reports Representing 25% of ETF’s Assets On Deck
Seeking Alpha 11h
Johnson & Johnson earnings on deck: What to expect

Johnson & Johnson (JNJ) is scheduled to announce Q3 earnings results on October 12th, after the closing bell, with analysts expecting a mixed print. Wall Stree...

Johnson & Johnson earnings on deck: What to expect
The Motley Fool 11h
Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Johnson & Johnson (JNJ +0.51%) and Pfizer (PFE +0.18%) both sell prescription medicines, offering investors different ways to own healthcare in 2026. Johnson &...

Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks 11h
Johnson & Johnson Q3 Earnings on October 13: Analysts See 10% Upside in JNJ Stock

Medical group Johnson & Johnson (JNJ) reports its Q3 earnings tomorrow – October 13. Wall Street expects the company to report earnings per share of $2.52, down...

24/7 Wall St. 15h
Treasury Bills vs Dividend Stocks: Which Income Stream Actually Fits Your Retirement

Investing Treasury Bills vs Dividend Stocks: Which Income Stream Actually Fits Your Retirement Treasury bills guarantee your rate until maturity while Johnson a...

Treasury Bills vs Dividend Stocks: Which Income Stream Actually Fits Your Retirement

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.